Literature DB >> 22847728

To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.

Simone Birocchi1, Giulia Cernuschi, Gian Marco Podda, Giorgio Costantino.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22847728     DOI: 10.1007/s11739-012-0816-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  30 in total

Review 1.  Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules.

Authors:  Peter Loewen; Karen Dahri
Journal:  Ann Hematol       Date:  2011-06-14       Impact factor: 3.673

2.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

Authors:  Brian F Gage; Yan Yan; Paul E Milligan; Amy D Waterman; Robert Culverhouse; Michael W Rich; Martha J Radford
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

3.  Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke.

Authors:  Gregg C Fonarow; Mathew J Reeves; Xin Zhao; DaiWai M Olson; Eric E Smith; Jeffrey L Saver; Lee H Schwamm
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

4.  Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.

Authors:  Gregory Y H Lip; Lars Frison; Jonathan L Halperin; Deirdre A Lane
Journal:  J Am Coll Cardiol       Date:  2010-11-24       Impact factor: 24.094

5.  Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.

Authors:  P M Kuijer; B A Hutten; M H Prins; H R Büller
Journal:  Arch Intern Med       Date:  1999-03-08

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Survival after stroke--the impact of CHADS2 score and atrial fibrillation.

Authors:  Karin M Henriksson; Bahman Farahmand; Saga Johansson; Signild Asberg; Andreas Terént; Nils Edvardsson
Journal:  Int J Cardiol       Date:  2009-01-13       Impact factor: 4.164

8.  Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Authors:  Julia Hippisley-Cox; Carol Coupland; Yana Vinogradova; John Robson; Rubin Minhas; Aziz Sheikh; Peter Brindle
Journal:  BMJ       Date:  2008-06-23

9.  [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].

Authors:  Martín Ruiz Ortiz; Elías Romo; Dolores Mesa; Mónica Delgado; Manuel Anguita; Amador López Granados; Juan C Castillo; José M Arizón; José Suárez de Lezo
Journal:  Rev Esp Cardiol       Date:  2008-01       Impact factor: 4.753

10.  Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome.

Authors:  Martín Ruiz Ortiz; Elías Romo; Dolores Mesa; Mónica Delgado; Manuel Anguita; Juan C Castillo; José M Arizón; José Suárez de Lezo
Journal:  Cardiology       Date:  2010-02-17       Impact factor: 1.869

View more
  2 in total

1.  Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage.

Authors:  Simone Birocchi; Gian Marco Podda
Journal:  Intern Emerg Med       Date:  2016-11-04       Impact factor: 3.397

2.  To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort.

Authors:  Serena Granziera; Giulia Bertozzo; Vittorio Pengo; Lucia Marigo; Gentian Denas; Florinda Petruzzellis; Katia Rossi; Tiziana Infante; Seena Jose Padayattil; Egle Perissinotto; Enzo Manzato; Giovanni Nante
Journal:  Intern Emerg Med       Date:  2015-04-21       Impact factor: 3.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.